Characteristic
|
Total (1346)
|
Male (N=896)
66.5%
|
Female (N=450)
33.5%
|
p-value
|
Age |
63.7 |
62.4 |
66.2 |
<0.001 |
Race |
|
|
|
0.43 |
White |
1,239 (92.1%) |
832 (92.9%) |
407 (90.4%) |
|
African American |
57 (4.2%) |
33 (3.7%) |
24 (5.3%) |
|
Asian |
18 (1.3%) |
10 (1.1%) |
8 (1.8%) |
|
Hispanic |
6 (0.4%) |
3 (0.3%) |
3 (0.7%) |
|
Other |
25 (1.9%) |
17 (1.9%) |
8 (1.8%) |
|
BMI |
32.01 |
32.24 |
31.51 |
0.52 |
CHADSVASC |
2 (1-3) |
2 (1-3) |
3 (2-4) |
<0.001 |
DM |
185 (13.7%) |
132 (14.7%) |
53 (11.8%) |
0.14 |
HTN |
802 (59.6%) |
538 (60.0%) |
264 (58.7%) |
0.63 |
CHF |
201 (14.9%) |
134 (15.0%) |
67 (14.9%) |
0.97 |
Stroke or TIA |
109 (8.1%) |
64 (7.1%) |
45 (10.0%) |
0.070 |
OSA |
269 (20.0%) |
205 (22.9%) |
64 (14.2%) |
<0.001 |
CKD |
54 (4.0%) |
33 (3.7%) |
21 (4.7%) |
0.38 |
Hyperlipidemia |
483 (35.9%) |
324 (36.2%) |
159 (35.3%) |
0.77 |
Asthma or COPD |
96 (7.1%) |
51 (5.7%) |
45 (10.0%) |
0.004 |
Smoking History |
335(24.8%) |
174(19.4%) |
97(21.5%) |
0.074 |
Anticoagulant |
1209(89.8%0 |
794(88.6%0 |
415(92.2%) |
0.012 |
ACEi |
246(18.2%) |
194(21.6%) |
52(11.5%) |
0.001 |
ARB |
259(19.2%) |
163(18.1%) |
96(21.3%) |
0.74 |
LA diameter (cm) |
4.41 |
4.47 |
4.31 |
0.024 |
LVEF by TEE (%) |
56.7 |
55.9 |
58.4 |
<0.001 |